CHOICE SPINE, LLC – Trademark Portfolio

Entity Type: 16

CHOICE SPINE, LLC holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 21 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 15 trademarks are registered and 3 are pending. Notable registered marks include VEO, RAVEN, TRITON, GIBRALT, and HARRIER. The owner is based in KNOXVILLE, TN.

400 ERIN DRIVE

KNOXVILLE, TN 37919

21 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CHOICE SPINE, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (21 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CHOICE SPINE, LLC have?

CHOICE SPINE, LLC has 21 U.S. trademarks filed with the USPTO. Of these, 15 registered, 3 pending, 1 abandoned, 2 cancelled.

What trademark classes does CHOICE SPINE, LLC file in?

CHOICE SPINE, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CHOICE SPINE, LLC's most well-known trademarks?

CHOICE SPINE, LLC's registered trademark portfolio includes well-known marks such as VEO, RAVEN, TRITON, GIBRALT, and HARRIER. These are among 15 currently registered trademarks in the portfolio.

What is CHOICE SPINE, LLC's trademark registration success rate?

CHOICE SPINE, LLC has a 83% trademark registration rate, with 15 out of 18 resolved applications resulting in successful registration. Currently, 3 applications are pending review.